A review of minodronic acid hydrate for the treatment of osteoporosis
Shinji Tanishima, Yasuo MorioDepartment of Orthopedic Surgery, Misasa Onsen Hospital, Misasa, Tottori, JapanAbstract: Minodronic acid hydrate was the first bisphosphonate developed and approved for osteoporosis treatment in Japan. With regard to inhibition of bone resorption, minodronic acid hydrate...
Guardado en:
Autores principales: | Tanishima S, Morio Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d0ab5805866f45c6b788d4b34bb2c585 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Role of zoledronic acid in the prevention and treatment of osteoporosis
por: Räkel A, et al.
Publicado: (2011) -
Osteoporosis in men: epidemiology and treatment with denosumab
por: Sidlauskas KM, et al.
Publicado: (2014) -
Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation
por: Imai K
Publicado: (2013) -
Management of osteoporosis in the aging male: Focus on zoledronic acid
por: Paul K Piper Jr, et al.
Publicado: (2009) -
Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment
por: Claudia Gagnon, et al.
Publicado: (2008)